Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
eNq1mN9v2jAQx9/5K6K8k/CjHe0UqDbWbkityiho014qkxzFzLXTsw10f/0cQjc6Oeow+I3Y5ntn393HJycX60cWLAElFbwbNqNGGABPRUb5QzecjK/qZ+FFr5YsyJIEKSNSdsPidzQFwmX0/eb6E5jVgGGvFiRiuoBUvVqnFWXRFyLnNyQv1gTJUtAseAQ1F1k3zLXajAaJVGhs9lYCf8qcpJDE25Hd2cX9ye54Ehdi/6GqJeA14Q9WUeBOmqlGBK76RMGDwOcKf9tO2lSOQAqNKQyJmg9RLGkGmdXEjDAJTkZmq+wOcMlAFUas4vEifZRO4mRB1iN4Gtid/mBm+2qt6o16s3N+0m63T1uNTsftsHDnqOxRMJuI0/tmp9U6b7Rj4DEjXGnpGJqhQEWYp6BQ2X+dV57sIDy9GfyMypyR52ghc9ejIkjMNKCpfn8bKXYwRsMjZs7sH32uGYv39HqypYUnjwsY9YXmqgIaVyPXg+gLrmBdHVE3zqn1NhcpyOPJ/hLczvihnjKauhLNMEeDVJPRoBpoR2TBRyJhgv5g8I3yTKzk8SGzG1RP3ucbTlpFc8ya963zs3fN01PnGvphMqjifrnUKHKIDX6oPIQqAz4Th/LEJKVd6iUlj5WNmyZHpIRBRZtTdySLScOXrsxbovsronLCKvr5cuyaHV814PPd5tMqTbPun7i6YdcHy00uVjq+f2aXBe6lAdZoB8dcqVy+j+PVahXNiaxLUy4QzfDYXN+5Sf11316u67J9KdnoyfVpeentFyDXQnvrQj+0Sd3+f9sMW20o1HBALEomeyPn4PL4MP7boXpze/gKHv7MbLpJoqjgvtocPbUqHoZ/E1d+hQYQt7MZrXgNqczLJC5fYnq1JC5eYXq138WH3jo=
RC8CrxuGfCgkZnX1
